JW Lifescience Corporation (KRX:234080)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,170
+30 (0.27%)
At close: Aug 3, 2026

JW Lifescience Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8,8648,3797,51120,2223,9204,923
Short-Term Investments
3,3382,1102,1108,12624,953155.05
Cash & Short-Term Investments
12,20210,4899,62228,34828,8735,078
Cash Growth
-53.90%9.01%-66.06%-1.82%468.59%95.88%
Accounts Receivable
42,42643,43643,04855,50553,42632,141
Other Receivables
-1,34416,784252.42346.01257.79
Receivables
42,42644,78059,83255,75753,77237,198
Inventory
30,15331,62235,44823,39922,06721,077
Prepaid Expenses
-131.29159.7824.78236.471,044
Other Current Assets
3,2081,266602.96305.5660.732.79
Total Current Assets
87,98888,289105,664107,834105,00864,430
Property, Plant & Equipment
125,660128,653132,051124,577131,555137,145
Long-Term Investments
585.31582.85558.5710,4194,3908,934
Goodwill
32,38932,38974,266950.99950.99950.99
Other Intangible Assets
44,07944,4903,2202,8703,1003,671
Long-Term Deferred Tax Assets
---15.81--
Long-Term Deferred Charges
178.39192.47248.81305.14484.8689.12
Other Long-Term Assets
22,67323,6109,3158,8657,4533,646
Total Assets
313,552318,206325,324255,836252,942219,467

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
16,67016,90019,61718,74015,11812,496
Accrued Expenses
-1,5401,6691,2711,156724.7
Short-Term Debt
7,50017,80027,70015,70036,68144,350
Current Portion of Long-Term Debt
32,84131,1378,11230,353336336
Current Portion of Leases
363.85296.15350.8244.91131.02159.77
Current Income Taxes Payable
3,2802,0468,5942,7393,6453,279
Other Current Liabilities
20,31414,70714,13625,41122,97622,557
Total Current Liabilities
80,96884,42880,17994,25980,04483,902
Long-Term Debt
--31,89916830,0071,610
Long-Term Leases
1,5461,3391,17646.6840.4231.91
Pension & Post-Retirement Benefits
4,1634,0504,001---
Long-Term Deferred Tax Liabilities
8,0387,7287,4061,8282,0112,243
Other Long-Term Liabilities
88.7382.81217.94141.95508.07187.8
Total Liabilities
94,80497,628124,87996,443112,61087,975

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
39,58639,58639,58639,58639,58639,586
Additional Paid-In Capital
28,33528,33528,33528,33528,33528,335
Retained Earnings
151,088152,918132,42298,22079,16070,319
Treasury Stock
-6,749-6,749-6,749-6,749-6,749-6,749
Comprehensive Income & Other
6,4876,4876,850000
Shareholders' Equity
218,748220,578200,445159,393140,332131,492
Total Liabilities & Equity
313,552318,206325,324255,836252,942219,467

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
42,25150,57369,23846,31367,19546,488
Net Cash (Debt)
-30,049-40,084-59,616-17,965-38,322-41,410
Net Cash Growth
------
Net Cash Per Share
-1941.12-2588.63-3850.39-1160.20-2474.87-2657.82
Filing Date Shares Outstanding
15.4815.4815.4815.4815.4815.48
Total Common Shares Outstanding
15.4815.4815.4815.4815.4815.48
Working Capital
7,0203,86125,48513,57424,965-19,472
Book Value Per Share
14126.8814245.0412944.8210293.699062.748491.82
Tangible Book Value
142,280143,699122,959155,573136,281126,870
Tangible Book Value Per Share
9188.549280.157940.7310046.958801.128193.30
Land
41,31341,31341,31332,45932,45932,459
Buildings
33,26434,08836,98339,82041,64842,618
Machinery
47,68650,04049,26951,45056,83644,976
Construction In Progress
1,5091,5992,987758.47440.7316,903